Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China
Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.
Hypertension, Resistant to Conventional Therapy
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
|Official Title:||Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension:An Observational Study in China|
blood samples,including serum, plasma and whole blood.
|Study Start Date:||January 2010|
|Primary Completion Date:||October 2011 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01459042
|Dep.endocrinology of Shanghai Ruijin Hospital, Shanghai Jiaotong university school of medcine|
|Shanghai, Shanghai, China, 200025|
|Principal Investigator:||Weiqing Wang, MD, PhD||Endocrinology Department of Ruijin Hospital affiliated Shanghai Jiao Tong University School of Medicine|